These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35889930)

  • 1. The Role of Resveratrol in Eye Diseases-A Review of the Literature.
    Bryl A; Falkowski M; Zorena K; Mrugacz M
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol and Ophthalmic Diseases.
    Abu-Amero KK; Kondkar AA; Chalam KV
    Nutrients; 2016 Apr; 8(4):200. PubMed ID: 27058553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases.
    Lançon A; Frazzi R; Latruffe N
    Molecules; 2016 Mar; 21(3):304. PubMed ID: 26950104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the Therapeutic and Pharmacological Properties of Resveratrol as a Nutraceutical Antioxidant Polyphenol in Health Promotion and Disease Prevention.
    Mohammadi S; Moghadam MD; Nasiriasl M; Akhzari M; Barazesh M
    Curr Rev Clin Exp Pharmacol; 2024; 19(4):327-354. PubMed ID: 38192151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.
    Ndiaye M; Philippe C; Mukhtar H; Ahmad N
    Arch Biochem Biophys; 2011 Apr; 508(2):164-70. PubMed ID: 21215251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and the eye: activity and molecular mechanisms.
    Bola C; Bartlett H; Eperjesi F
    Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):699-713. PubMed ID: 24652235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol: A Vital Therapeutic Agent with Multiple Health Benefits.
    Kaur A; Tiwari R; Tiwari G; Ramachandran V
    Drug Res (Stuttg); 2022 Jan; 72(1):5-17. PubMed ID: 34412126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance.
    Goutham G; Manikandan R; Beulaja M; Thiagarajan R; Arulvasu C; Arumugam M; Setzer WN; Daglia M; Nabavi SF; Nabavi SM
    Biomed Pharmacother; 2017 Feb; 86():232-241. PubMed ID: 28006748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.
    Wang B; Sun J; Li X; Zhou Q; Bai J; Shi Y; Le G
    Nutr Res; 2013 Nov; 33(11):971-81. PubMed ID: 24176237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol as a therapeutic agent for neurodegenerative diseases.
    Sun AY; Wang Q; Simonyi A; Sun GY
    Mol Neurobiol; 2010 Jun; 41(2-3):375-83. PubMed ID: 20306310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats.
    Javkhedkar AA; Quiroz Y; Rodriguez-Iturbe B; Vaziri ND; Lokhandwala MF; Banday AA
    Am J Physiol Regul Integr Comp Physiol; 2015 May; 308(10):R840-6. PubMed ID: 25761698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular protective effects of resveratrol.
    Bradamante S; Barenghi L; Villa A
    Cardiovasc Drug Rev; 2004; 22(3):169-88. PubMed ID: 15492766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol and stroke: from chemistry to medicine.
    Nabavi SF; Li H; Daglia M; Nabavi SM
    Curr Neurovasc Res; 2014; 11(4):390-7. PubMed ID: 25219659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pharmacological Properties of Red Grape Polyphenol Resveratrol: Clinical Trials and Obstacles in Drug Development.
    Farhan M; Rizvi A
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effects of resveratrol.
    Frémont L
    Life Sci; 2000 Jan; 66(8):663-73. PubMed ID: 10680575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol.
    Malhotra A; Bath S; Elbarbry F
    Oxid Med Cell Longev; 2015; 2015():803971. PubMed ID: 26180596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and potential applications of free radical scavengers in glaucoma.
    Aslan M; Dogan S; Kucuksayan E
    Redox Rep; 2013; 18(2):76-87. PubMed ID: 23485101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol and cardiovascular system-the unfulfilled hopes.
    Chudzińska M; Rogowicz D; Wołowiec Ł; Banach J; Sielski S; Bujak R; Sinkiewicz A; Grześk G
    Ir J Med Sci; 2021 Aug; 190(3):981-986. PubMed ID: 33219913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
    Al-Hussaini H; Kilarkaje N
    Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of diabetic retinopathy and neuropathy by resveratrol: Review on its molecular mechanisms of action.
    Ahmad I; Hoda M
    Life Sci; 2020 Mar; 245():117350. PubMed ID: 31982401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.